cholestyramine

Generic: cholestyramine

Labeler: puracap laboratories llc dba blu pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cholestyramine
Generic Name cholestyramine
Labeler puracap laboratories llc dba blu pharmaceuticals
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

cholestyramine 4 g/9g

Manufacturer
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS

Identifiers & Regulatory

Product NDC 24658-266
Product ID 24658-266_7c3a3854-b045-4b67-ba97-eb980be64817
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074557
Listing Expiration 2026-12-31
Marketing Start 2023-03-14

Pharmacologic Class

Established (EPC)
bile acid sequestrant [epc]
Mechanism of Action
bile-acid binding activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24658266
Hyphenated Format 24658-266

Supplemental Identifiers

RxCUI
848943
UNII
4B33BGI082
NUI
N0000180292 N0000175365

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cholestyramine (source: ndc)
Generic Name cholestyramine (source: ndc)
Application Number ANDA074557 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 g/9g
source: ndc
Packaging
  • 378 g in 1 JAR (24658-266-93)
  • 60 POUCH in 1 CARTON (24658-266-95) / 9 g in 1 POUCH
  • 378 g in 1 CAN (24658-266-97)
source: ndc

Packages (3)

Ingredients (1)

cholestyramine (4 g/9g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7c3a3854-b045-4b67-ba97-eb980be64817", "openfda": {"nui": ["N0000180292", "N0000175365"], "unii": ["4B33BGI082"], "rxcui": ["848943"], "spl_set_id": ["d82647da-465b-4e2e-8cf8-72d50f047b3e"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "378 g in 1 JAR (24658-266-93)", "package_ndc": "24658-266-93", "marketing_start_date": "20240429"}, {"sample": false, "description": "60 POUCH in 1 CARTON (24658-266-95)  / 9 g in 1 POUCH", "package_ndc": "24658-266-95", "marketing_start_date": "20230314"}, {"sample": false, "description": "378 g in 1 CAN (24658-266-97)", "package_ndc": "24658-266-97", "marketing_start_date": "20230314"}], "brand_name": "CHOLESTYRAMINE", "product_id": "24658-266_7c3a3854-b045-4b67-ba97-eb980be64817", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "24658-266", "generic_name": "cholestyramine", "labeler_name": "PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CHOLESTYRAMINE", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/9g"}], "application_number": "ANDA074557", "marketing_category": "ANDA", "marketing_start_date": "20230314", "listing_expiration_date": "20261231"}